Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China · Delayed Price · Currency is CNY 22.50
-0.15 (-0.66%)
Sep 10, 2026, 3:00 PM CST
SHA:600993 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,879 | 3,816 | 3,680 | 3,098 | 3,497 | 3,363 |
Other Revenue | 50.46 | 50.46 | 48.5 | 38.3 | 35.12 | 22.53 |
| 3,929 | 3,867 | 3,728 | 3,137 | 3,532 | 3,385 | |
Revenue Growth | 4.80% | 3.72% | 18.85% | -11.20% | 4.35% | 21.26% |
Cost of Revenue | 2,052 | 1,966 | 1,997 | 1,829 | 2,038 | 2,019 |
Gross Profit | 1,877 | 1,901 | 1,731 | 1,307 | 1,494 | 1,366 |
Selling, General & Admin | 1,101 | 1,147 | 1,051 | 825.21 | 886.06 | 818.05 |
Research & Development | 72.56 | 78.11 | 66.69 | 69.01 | 77.89 | 66.73 |
Other Operating Expenses | 28.73 | 25.35 | 17.6 | 24.39 | 26.16 | 25.06 |
Operating Expenses | 1,208 | 1,256 | 1,144 | 922.54 | 1,000 | 912.9 |
Operating Income | 669.63 | 644.71 | 587.12 | 384.73 | 494.16 | 453.38 |
Interest Expense | -7.38 | -7.38 | -7.38 | -16.85 | -11.69 | -10.21 |
Interest & Investment Income | 79.53 | 70.05 | 78.88 | 151.5 | 98.92 | 78.85 |
Currency Exchange Gain (Loss) | 0.13 | 0.13 | -0.06 | 0.05 | 0.04 | -0.21 |
Other Non Operating Income (Expenses) | -8.94 | 2.16 | 0.99 | -3.78 | -6.22 | -4.92 |
EBT Excluding Unusual Items | 732.98 | 709.68 | 659.55 | 515.65 | 575.22 | 516.89 |
Impairment of Goodwill | -2.28 | -2.28 | - | - | - | - |
Gain (Loss) on Sale of Investments | -5.25 | -5.77 | -6.57 | -0.35 | -38.06 | 17.63 |
Gain (Loss) on Sale of Assets | -5.24 | -5.21 | -0.14 | 1.12 | -0.01 | -0.5 |
Asset Writedown | -1.05 | -0.01 | -5.25 | - | -0.34 | -0.44 |
Other Unusual Items | 12.59 | 12.59 | 9.96 | 8.28 | 22.33 | 14.58 |
Pretax Income | 731.75 | 709 | 657.55 | 524.7 | 559.14 | 548.16 |
Income Tax Expense | 106.21 | 103.29 | 109.26 | 72.86 | 79.78 | 74.11 |
Earnings From Continuing Operations | 625.54 | 605.71 | 548.3 | 451.84 | 479.35 | 474.05 |
Minority Interest in Earnings | -24.66 | -24.22 | -20.2 | -8.59 | -0.78 | -9.46 |
Net Income | 600.88 | 581.49 | 528.09 | 443.25 | 478.57 | 464.59 |
Net Income to Common | 600.88 | 581.49 | 528.09 | 443.25 | 478.57 | 464.59 |
Net Income Growth | 7.41% | 10.11% | 19.14% | -7.38% | 3.01% | 10.87% |
Shares Outstanding (Basic) | 432 | 431 | 429 | 430 | 431 | 430 |
Shares Outstanding (Diluted) | 432 | 431 | 429 | 430 | 431 | 430 |
Shares Change | 1.13% | 0.32% | -0.23% | -0.19% | 0.22% | -0.43% |
EPS (Basic) | 1.39 | 1.35 | 1.23 | 1.03 | 1.11 | 1.08 |
EPS (Diluted) | 1.39 | 1.35 | 1.23 | 1.03 | 1.11 | 1.08 |
EPS Growth | 6.22% | 9.76% | 19.42% | -7.21% | 2.78% | 11.34% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 638.24 | 481.07 | 293.76 | 355.7 | 266.84 | 532.07 |
Free Cash Flow Per Share | 1.48 | 1.12 | 0.68 | 0.83 | 0.62 | 1.24 |
Dividend Per Share | 0.700 | 0.700 | 0.620 | 0.400 | 0.350 | 0.350 |
Dividend Growth | 12.90% | 12.90% | 55.00% | 14.29% | 0% | 16.67% |
Gross Margin | 47.78% | 49.16% | 46.43% | 41.68% | 42.30% | 40.36% |
Operating Margin | 17.04% | 16.67% | 15.75% | 12.26% | 13.99% | 13.39% |
Profit Margin | 15.29% | 15.04% | 14.17% | 14.13% | 13.55% | 13.73% |
Free Cash Flow Margin | 16.24% | 12.44% | 7.88% | 11.34% | 7.55% | 15.72% |
EBITDA | 726.65 | 703.43 | 638.41 | 434.2 | 541.14 | 495.12 |
EBITDA Margin | 18.49% | 18.19% | 17.13% | 13.84% | 15.32% | 14.63% |
D&A For EBITDA | 57.01 | 58.72 | 51.29 | 49.48 | 46.98 | 41.74 |
EBIT | 669.63 | 644.71 | 587.12 | 384.73 | 494.16 | 453.38 |
EBIT Margin | 17.04% | 16.67% | 15.75% | 12.26% | 13.99% | 13.39% |
Effective Tax Rate | 14.51% | 14.57% | 16.61% | 13.89% | 14.27% | 13.52% |
Revenue as Reported | 3,867 | 3,867 | 3,728 | 3,137 | 3,532 | 3,385 |
Advertising Expenses | - | 222.35 | 161.64 | 72.56 | 81.25 | 59.99 |